Amphastar Pharmaceuticals, Inc. (AMPH) Operating margin 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) operating margin by fiscal year — reported operating income divided by reported revenue.
19.5%FY2025 · since FY2016: 6.0% → 19.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 19.5% | -8.6 pp |
| FY2024 | 28.1% | -2.5 pp |
| FY2023 | 30.6% | +9.0 pp |
| FY2022 | 21.5% | +5.6 pp |
| FY2021 | 16.0% | +12.8 pp |
| FY2020 | 3.1% | +3.1 pp |
| FY2019 | 0.0% | +2.9 pp |
| FY2018 | -2.9% | -2.4 pp |
| FY2017 | -0.5% | -6.6 pp |
| FY2016 | 6.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AMPH financial trends
AMPH RevenueAMPH Net incomeAMPH Net marginAMPH Gross profitAMPH Gross marginAMPH Operating incomeAMPH Operating cash flowAMPH Free cash flowAMPH Capital expendituresAMPH Return on equityAMPH Stock buybacksAMPH Dividends paidAMPH Total assetsAMPH Total liabilitiesAMPH Shareholders’ equityAMPH overview →